Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer
NCT04341883
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Cervical Cancer
Interventions
DRUG:
anti-PD-1+Albumin-Bound Paclitaxel
Sponsor
Sun Yat-sen University